Stock listing

ATRC Stock Price, News, Filings & Events — Atricure, Inc.

Selected listing: ATRC · NASDAQ · USD · US

This page tracks Atricure, Inc.'s ATRC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ATRC:NASDAQ. ATRC:NASDAQ is the stock-level entry point for investors researching Atricure, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Atricure, Inc. is a public company listed under the ticker ATRC, operating in the American market. The company has a market capitalization of approximately $1.77 billion. Atricure focuses on developing innovative medical devices for the treatment of atrial fibrillation and other cardiac conditions.

ATRC:NASDAQUSDUSUpdated August 21, 2026
Atricure, Inc. logo
Ticker
ATRC:NASDAQ
Asset type
Stock
Market cap
$2.49B
Sector
Health Technology
Industry
Medical Specialties
Exchange
NASDAQ
Currency
USD

Atricure, Inc. ATRC:NASDAQ stock context

This page tracks Atricure, Inc.'s ATRC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ATRC:NASDAQ. ATRC:NASDAQ is the stock-level entry point for investors researching Atricure, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Atricure, Inc. is a public company listed under the ticker ATRC, operating in the American market. The company has a market capitalization of approximately $1.77 billion. Atricure focuses on developing innovative medical devices for the treatment of atrial fibrillation and other cardiac conditions.

Latest news from Atricure, Inc.

All Atricure, Inc. news →

Research Atricure, Inc.

Alternate listings